Thank you for subscribing!
Next Investors Oct 22, 2022
We have all seen when a new investment theme goes through an initial period of hype, the peak of inflated expectations and then the trough of disillusionment. Today we will look at how this hype cycles affects to investment themes we are closely watching for 2023: Weed and Gold
Finfeed Archived Apr 22, 2021
Medicinal cannabis, CBD and hemp healthcare products company, Bod Australia Limited (ASX: BDA) has provided its shareholders an update for the Q3FY2021 quarter, ended 31 March 2021.
Finfeed Archived Apr 19, 2021
Creso Pharma Limited’s (ASX:CPH, FRA:1X8) target acquisition company Halucencex Life Sciences Inc. has signed a non-binding Letter of Intent (LOI) with leading nanotechnology company Sixth Wave Inc. as California pushes to decriminalise psychedelics, which highlights the ongoing acceptance and regulatory shift towards psychedelics as an alternative treatment route for debilitating mental health conditions.
Finfeed Archived Apr 12, 2021
Creso Pharma Limited (ASX: CPH, FRA:1X8) has provided an update regarding target acquisition company, Halucenex Life Sciences, outlining its entry into an advisory agreement with Growing Together Research Inc. (GTR) to explore the genome sequencing of natural psilocybe.
Get expert stock analysis direct in your inbox
Finfeed Archived Apr 06, 2021
Creso Pharma (ASX: CPH) has appointed a US Director of Business Development just as New York State has legalised recreational cannabis. New York State is expected to become one of the largest recreational markets in the US valued at US$4.2BN.
Finfeed Archived Mar 17, 2021
Bod Australia (ASX: BDA) is a cannabis centric healthcare company, with well-branded premium, proven and trusted products within two distinct verticals: Medical Cannabis and CBD and Hemp Consumer products.
Finfeed Archived Feb 15, 2021
Following the successful in vitro findings, Neurotech (ASX: NTI) has begun designing a phase I/II study to assess the safety and efficacy of the novel NTI/Dolce strain in a paediatric population.
Finfeed Archived Jan 29, 2021
Creso Pharma looks set to start the year on a strong note after an impressive performance in the December quarter of 2020
Next Investors Archived Oct 13, 2020
While Creso Pharma (ASX: CPH) continues to sign purchase orders and has appointed Bruce Linton as an advisor, it is a highly speculative investment, and our intent is to hold for the coming months through to Christmas to see how the company’s strategy plays out.
Finfeed Archived Aug 31, 2020
Joe Biden announced that Kamala Harris is his pick for Vice President, should he win the upcoming US Presidential election in November. But what could a Biden/Harris ticket mean for cannabis legalization?
Finfeed Archived Jun 01, 2020
MMJ Group Holdings Limited (ASX:MMJ; OTC:MMJJF) was a foundation investor in Embark Health, which has now commenced production of bubble hash, rosin and dry sift.
Finfeed Archived May 29, 2020
Cannabis enthusiasts purchase terps and incorporate them into everything from homemade brownies to vape juice. But there’s one industry that’s had surprisingly less of a symbiotic relationship with terpenes than anyone might have expected; namely the cannabis industry.
Finfeed Archived Apr 28, 2020
Canada’s WeedMD is pivoting to help the broader health sector as COVID-19 continues to put lives in danger.
Finfeed Archived Apr 16, 2020
MMJ Group Holdings Limited (ASX: MMJ/OTC: MMJJF) has agreed to provide a C$2.5 million secured convertible note facility to Sequoya Cannabis Limited.
Finfeed Archived Apr 03, 2020
Federal or State governments could consider legalising recreational cannabis to fill the budget black holes they will face post the COVID-19 pandemic.
Finfeed Archived Mar 27, 2020
Reports show that anxiety-driven consumers are now stockpiling cannabis in at least four US states thanks to COVID-19.
Finfeed Archived Mar 20, 2020
As fears surrounding the Coronavirus drive the markets down, one ASX-listed pot stock could triumph amid the COVID-19 crisis.
Finfeed Archived Mar 17, 2020
Will cannabis stocks survive the Coronavirus? The strong will survive and there could be bargains to be had.
Join Our Mailing List
